Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018 (2018), Article ID 7906531, 9 pages
https://doi.org/10.1155/2018/7906531
Research Article

Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging

1Nankai University School of Medicine, Tianjin 300071, China
2The Key Lab of Bioactive Materials, Ministry of Education, The College of Life Science, Nankai University, Tianjin 300071, China
3Department of Ophthalmology, Ophthalmology and Visual Science Key Lab of PLA, Chinese PLA General Hospital, Beijing 100853, China
4State Key Laboratory of Kidney Diseases Chinese PLA General Hospital, Beijing 100853, China
5Faculty of Clinical Medicine, Zhejiang University School of Medicine, Zhejiang 310058, China
6Department of Cardiology, Rizhao Hospital of Traditional Chinese Medicine, Shandong 276800, China
7Beijing Engineering Laboratory of Perinatal Stem Cells, Beijing Institute of Health and Stem Cells, Health & Biotech Co., Beijing 100176, China
8State Key Lab of Experimental Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China

Correspondence should be addressed to Xiaojing Wang; nc.ca.smachi@gnijoaixgnaw and Zongjin Li; nc.ude.iaknan@ilnijgnoz

Received 7 November 2017; Accepted 27 December 2017; Published 25 March 2018

Academic Editor: Hui Li

Copyright © 2018 Hongyan Tao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Lin, Q. OuYang, X. Zhou et al., “A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure,” Cell Research, vol. 17, no. 12, pp. 999–1007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. E. Reubinoff, M. F. Pera, C. Y. Fong, A. Trounson, and A. Bongso, “Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro,” Nature Biotechnology, vol. 18, no. 4, pp. 399–404, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Oottamasathien, Y. Wang, K. Williams et al., “Directed differentiation of embryonic stem cells into bladder tissue,” Developmental Biology, vol. 304, no. 2, pp. 556–566, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. H. Kim, H. W. Kim, K. J. Cha et al., “Nanotopography promotes pancreatic differentiation of human embryonic stem cells and induced pluripotent stem cells,” ACS Nano, vol. 10, no. 3, pp. 3342–3355, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Rambhatla, C. P. Chiu, P. Kundu, Y. Peng, and M. K. Carpenter, “Generation of hepatocyte-like cells from human embryonic stem cells,” Cell Transplantation, vol. 12, no. 1, pp. 1–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Ye, R. Mayberry, C. Y. Lo et al., “Generation of human female reproductive tract epithelium from human embryonic stem cells,” PLoS One, vol. 6, no. 6, article e21136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Su, M. Zhou, Y. Zheng et al., “Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation,” Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 840–848, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. B. Cibelli, K. A. Grant, K. B. Chapman et al., “TParthenogenetic stem cells in nonhuman primates,” Science, vol. 295, no. 5556, p. 819, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kim, K. Ng, P. J. Rugg-Gunn et al., “Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer,” Cell Stem Cell, vol. 1, no. 3, pp. 346–352, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Evans and M. H. Kaufman, “Establishment in culture of pluripotential cells from mouse embryos,” Nature, vol. 292, no. 5819, pp. 154–156, 1981. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Liu, L. Yin, X. Yan et al., “Directing the differentiation of parthenogenetic stem cells into tenocytes for tissue-engineered tendon regeneration,” Stem Cells Translational Medicine, vol. 6, no. 1, pp. 196–208, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. D. A. Isaev, I. Garitaonandia, T. V. Abramihina et al., “In vitro differentiation of human parthenogenetic stem cells into neural lineages,” Regenerative Medicine, vol. 7, no. 1, pp. 37–45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Schuldiner, J. Itskovitz-Eldor, and N. Benvenisty, “Selective ablation of human embryonic stem cells expressing a “suicide” gene,” Stem Cells, vol. 21, no. 3, pp. 257–265, 2003. View at Publisher · View at Google Scholar
  14. N. E. Huskey, T. Guo, K. J. Evason et al., “CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation,” Stem Cell Reports, vol. 4, no. 3, pp. 374–389, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Tang, A. S. Lee, J. P. Volkmer et al., “An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells,” Nature Biotechnology, vol. 29, no. 9, pp. 829–834, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Chung, B. S. Shin, E. Hedlund et al., “Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation,” Journal of Neurochemistry, vol. 97, no. 5, pp. 1467–1480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. B. Choo, H. L. Tan, S. N. Ang et al., “Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1,” Stem Cells, vol. 26, no. 6, pp. 1454–1463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Knoepfler, “Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine,” Stem Cells, vol. 27, no. 5, pp. 1050–1056, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Y. Zhang, P. E. de Almeida, and J. C. Wu, Teratoma Formation: A Tool for Monitoring Pluripotency in Stem Cell Research, StemBook, Cambridge (MA), 2008.
  20. W. Su, L. Leng, Z. Han, Z. He, and Z. Li, “Bioluminescence imaging of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction,” Methods in Molecular Biology, vol. 1052, pp. 203–215, 2013. View at Publisher · View at Google Scholar
  21. L. Leng, Y. Wang, N. He et al., “Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy,” Biomaterials, vol. 35, no. 19, pp. 5162–5170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Liu, X. Ye, L. Mao et al., “Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction,” Cardiovascular Research, vol. 97, no. 2, pp. 208–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Liang, Z. Yue, W. Du et al., “Molecular imaging of inducible VEGF expression and tumor progression in a breast cancer model,” Cellular Physiology and Biochemistry, vol. 42, no. 1, pp. 407–415, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Wang, H. Sang, K. Zhang et al., “Stat3 phosphorylation is required for embryonic stem cells ground state maintenance in 2i culture media,” Oncotarget, vol. 8, no. 19, pp. 31227–31237, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. J. Li, Z. Z. Wang, Y. Z. Zheng et al., “Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation,” Journal of Cellular Biochemistry, vol. 95, no. 3, pp. 559–570, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Mao, M. Zhu, X. Zhang et al., “A macroporous heparin-releasing silk fibroin scaffold improves islet transplantation outcome by promoting islet revascularisation and survival,” Acta Biomaterialia, vol. 59, pp. 210–220, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Wang, K. Zhang, H. Tao et al., “Molecular imaging of tumor angiogenesis and therapeutic effects with dual bioluminescence,” Current Pharmaceutical Biotechnology, vol. 18, no. 5, pp. 422–428, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. N. He, G. Feng, Y. Li et al., “Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer,” Stem Cell Research & Therapy, vol. 7, no. 1, p. 95, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Feng, J. Zhang, Y. Li et al., “IGF-1 C domain-modified hydrogel enhances cell therapy for AKI,” Journal of the American Society of Nephrology, vol. 27, no. 8, pp. 2357–2369, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Rong, X. Fu, M. Wang, and Y. Xu, “A scalable approach to prevent teratoma formation of human embryonic stem cells,” The Journal of Biological Chemistry, vol. 287, no. 39, pp. 32338–32345, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Piao, T. Major, G. Auyeung et al., “Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation,” Cell Stem Cell, vol. 16, no. 2, pp. 198–210, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Gonzalez, I. Garitaonandia, M. Poustovoitov et al., “Neural stem cells derived from human parthenogenetic stem cells engraft and promote recovery in a nonhuman primate model of Parkinson’s disease,” Cell Transplantation, vol. 25, no. 11, pp. 1945–1966, 2016. View at Publisher · View at Google Scholar · View at Scopus